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Adenoid cystic carcinoma (ACC) of the breast is a rare
type of tumor, seen in less than 0.1% of all breast
carcinomas.1 The first description of ACC by
Geschickter dates back to 1945.2 In most cases, it is
shown to be less aggressive than ACC in other sites of
the body, such as the lung, and salivary glands.3 The
tumor consists of an epithelial and a myoepithelial
component and is arranged in a variety of patterns, of
which the cribriform and solid patterns predominate.4
Treatment options vary from simple lumpectomy to
radical mastectomy. The exact incidence of ACC of
breast in Pakistan is not known. In a large local study, it
was seen that out of the 6718 cases of breast
carcinomas, only 2 were found to be diagnosed with
ACC.5 No case series on ACC-breast in Pakistan has
been done to date. The aim of this study was to evaluate
the findings from 7 patients with adenoid cystic
carcinoma of the breast that were reported in our
section.
The authors retrieved hematoxylin and eosin (H and E)
stained slides of 7 cases of ACC of breast reported
between 2002 and 2013 in the Section of
Histopathology, the Aga Khan University Hospital
(AKUH), Karachi, Pakistan. Four out of the 7 patients
were treated at the AKUH. Clinical data of these 4 cases
was obtained by reviewing past medical records, while
those of the remaining 3 referral cases for histo-
pathology, was done via direct communication with the
patient. Histological findings were reviewed by 2
pathologists. In 4 cases, immunohistochemical staining
was performed: Cytokeratin Cam 5.2, CD10, S-100, p63
staining in 1 case, CD117 in 1 case, synaptophysin in 1
case, ASMA in 2 cases, 34-beta-E12 in 2 cases,
cytokeratin AE1/AE3 staining in 2 cases. HER-2/neu and
Estrogen/Progesterone receptor (ER/PR) testing was
done in 2 cases.
The 7 cases occurred in women whose ages ranged
from 38 to 59 years (mean = 47 years). A palpable lump
was the main presenting complaint in 6 out of 7 cases,
with 4 cases involving the left breast and 2 involving the
right breast. Laterality was not known in 1 case. Two of
the lumps were located in the periareolar region, 2 in the
left upper quadrant, and 1 each in the right upper
quadrant and the left lower inner quadrant. Three cases
also involved associated skin with nipple retraction and
tethering of the skin. Procedures performed included
modified radical mastectomy, wide excision of the lesion,
sentinel lymph node biopsy, needle localization
excisional biopsy and lumpectomy.
Most of the tumors were firm in consistency and the
colour of the tumors grossly was yellowish-pink, grey-
brown and tan. One was noted to be well circumscribed
while another had infiltrative borders (Figure 1).
Hemorrhage was noted in 1 case. The tumor size
ranged from 1.2 cm to 4 cm, with a mean tumor size of
2.3 cm.
Histologically, the tumor consisted of a ductal epithelial
component and a basaloid myoepithelial component.
The classic cribriform pattern was seen as a dominant
component in 4 cases, in which large cystic spaces lined
by basement membrane-like material is seen and as a
small component in 1 case (Figures 2A and B). A tubular
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pattern was seen as a dominant component in 2 cases
and small component in 4 cases. In 1 case (case #5),
the tumor tubules were seen to be arranged around
ducts in a targetoid fashion, similar to that seen in
lobular carcinoma (Figure 2C). In another case (case
#6), secretions were seen in the tubules. A solid pattern
was seen as a dominant component in 2 cases and
small component in 2 cases, in which nests and clusters
of cells were seen with pseudoglandular lumina.
Sclerotic stroma was seen in 2 cases while hyalinized
stroma was seen in 2 cases.
Typical characteristics of tumor cells in adenoid cystic
carcinoma of the breast were seen as hyperchromatic
nuclei, inconspicuous nucleoli and eosinophilic
cytoplasm. Mitoses ranged from 2/10 to 22/10 high
power fields. Infiltrative margins were seen in 2 cases
(cases #1 and #5 in Table I). Three cases each were
grade I and II, and one was grade III, according to the
Modified Bloom and Richardon's grading system.
Perineural invasion was noted in 3 cases. In the
specimen of sentinel lymph node biopsy, 1 of the 8
lymph nodes was positive for metastasis (Figure 2D). In
the modified radical mastectomy specimen, the lymph
nodes were found to be tumor free (0/18) but did show
reactive hyperplasia. In the excision biopsy specimen,
the lymph nodes were also found to be tumor free (0/5).
Evidence of extranodal metastasis was seen in the
vertebral body in 1 case (case # 5). Immuno-
histochemical staining indicated cytokeratin AE1/AE3,
CAM5.2, CD10, 34-Beta-E12 positive results in 1 case,
34-Beta-12 patchy positive in another case, CD117 in
1 case, HER-2/neu positive in 2 cases and ER/PR
positive in 1 case. A special stain, PAS alcian blue, was
positive in 1 case. The summary of all the findings are
shown in Table I.
Three patients were started on tamoxifen after removal
of the breast lump, 1 was started on radiotherapy and
2 underwent 5 cycles of chemotherapy. The follow-up
period varied from 12.5 months to 138.5 months with a
mean time period of 61.25 months. One patient lost to
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Figure 1: Gross appearance of ACC of breast. The tumor has grey-white
solid cut surface.
Figure 2: (A) Tumor is present beneath the skin as tubules and cribriform
pattern (H&E, 4 x magnifications). (B) Predominant cribriform pattern with
numerous cylinders containing homogenous acidophilic material (H&E,10x
magnification). (C) Arrangement of tumor tubules around a duct reminiscent
of targetoid pattern (H&E, 4x magnification). Lymph node metastasis (H&E,
10x magnification).
Table I: Summary of cases of adenoid cystic carcinoma of breast (n=7).
Age Procedure Laterality Tumor size Growth patterns Mitosis Grade IHC profile Lymph nodes Follow-up
51 Needle localization Left 1.2x0.7 Cribriform 4/10 1 - - -
excision biopsy
50 Lumpectomy Left 3 Cribriform, tubular 5/10 1 ER/PR +ve - -
45 Frozen biopsy + Right 3x2.7 Dominant component: Cribriform 2/10 1 HER2/neu: +1 0/18 -
Modified radical Small components: Tubular and
mastectomy solid pattern Perineural invasion
38 Lumpectomy Not known 1.3x1.0 Dominant component: tubular
Small component: cribriform 22/10 2 - - -
46 Excision biopsy Left 4x2 Dominant component: Solid 12-13/10 2 -Cytokeratin AE1/AE3 +ve 0/5 Vertebral body 
Small component: tubular pattern -Cytokeratin CAM 5.2: +ve metastasis
Perinueural invasion + -CD10: +ve
-34-Beta-E12+ve
59 Sentinel lymph node Right 2.5x2 Dominant component: Cribriform 12/10 2 -ER/PR +ve 1/8 LNs positive - 
biopsy, wide excision Small components: Tubular and -Her2/neu: +ve for metastasis
of lesion solid pattern 
Perineural invasion +
40 Wide local excision Left 1.5 Dominant component: Solid 13/10 3 24BE12: patchy +ve - -
Small component: Tubular pattern CD117: +ve
No PNI
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follow-up. None of the cases had recurrence of adenoid
cystic carcinoma of the breast; however, vertebral body
metastasis was seen in 1 case, 4 months after surgery.
Benign histological findings, occasional foci of atypical
lobular hyperplasia and microcalcifications were seen in
1 case, after which a lump excision was performed (case
#1). In addition, a simple mastectomy and excision of
axillary lymph nodes were performed to remove the
residual tumor in another case (case #5). At the time of
diagnosis, metastasis to a single lymph node was seen
in 1 case (case #6).
Adenoid cystic carcinoma of the breast is a very rare
tumor, seen in less than 0.1% of all breast carcinoma
cases.1 It is shown to be less malignant than ACC
elsewhere in the body, such as the salivary gland, the
tracheobronchial tree and the Bartholin's gland.3 In a
case series on adenoid cystic carcinoma of the salivary
glands by Nascimento et al., local recurrence was seen
in 37% of cases and metastasis in 50% of cases.6 In this
case series, only 1 patient was found to have metastasis
to a non-sentinel lymph node at the time of diagnosis
and only 1 patient was found to have distant metastasis
to the vertebral body after surgical removal of ACC-
breast. One of the largest studies in the literature
indicated that a mere 7 patients out of 225 presented
with distant metastasis or unknown stage at the time of
diagnosis,7 thus highlighting the difference in the degree
of malignancy between the tumor and its counterparts
elsewhere in the body.
The mean age at the time of diagnosis in this case
series, 47 years, conforms to that seen in the vast
majority of studies in the literature, where it is seen to fall
in the 4th and 5th decade of life.3,8,9 The mean tumor
size of 2.3 cm also falls in the size bracket most
commonly seen in the literature of 1.8 to 3.7 cm.8
Histologically, as seen in previous studies in the
literature, the cribriform and solid histological patterns
are the dominant patterns seen while a tubular pattern is
less commonly seen.4,8 The vast majority of studies in
the literature show that ACC of the breast tumors are
generally ER/PR and HER-2/neu negative and were
shown to have a good prognostic value. However, there
are some studies that indicate ER/PR positive ACC-
breast tumors.9 In their study on the subject, Alpino and
Clark noted that 46% of cases revealed a positive ER
status and 36% showed a positive PR status.9 Three out
of our 7 cases revealed a positive HER-2/neu and/or
ER/PR status. None of these 3 cases resulted in local
recurrence, while only 1 resulted in metastasis to 1
lymph node. Furthermore, an ER/PR positive status is
very rarely seen in ACCs' more malignant counterpart
tumors such as those seen in the salivary gland,
suggesting that perhaps a positive ER and PR status
does not significantly affect the prognosis of the tumor.
Furthermore, it points to the cell origin of the tumor from
the breast's ductal element as opposed to its glandular
element.10
Due to the rarity of the disease, the most optimal
treatment option remains controversial. However, more
often than not, simple mastectomy is considered to be
the most preferred treatment modality.4 Local recurrence
of ACC-breast is often seen to follow local excision,8,9
but it was not seen in any of these cases. Various
treatment modalities were used in this case series,
ranging from lumpectomy to radical mastectomy and
most followed a good outcome.
Perineural invasion is reported to be a rare finding.3,6
However, in this case series, perineural invasion was
seen in 3 of our cases, suggesting that it may be a poor
prognostic factor for the disease.
No preferences to either breast or unilateralism were
most common findings seen in the literature. In this case
series, 4 cases occurred in the left breast, while the
remaining 2 occurred in the right breast. Lymph node
metastasis occurred in a case of ACC in the right breast,
vertebral body metastasis occurred in a case of ACC in
the left breast, and the remaining all cases had good
prognosis, suggesting that laterality does not hold any
significant value. There are multiple reports in the
literature that indicate no significant predilection to either
location of the lump in the central region or the upper
quadrant. Similarly, our case series indicated that 3 of
our cases occurred in the upper quadrant, 2 occurred in
the central region and 1 occurred in the lower inner
quadrant.
Consistent with data in the literature, this case series
indicates that ACC-breast has a good prognostic value,
with rare local recurrence after removal of the tumor and
of distant metastasis. Other characteristics of the tumor
were also seen in this case series, such as a small tumor
size, preferential occurrence in the 4th and 5th decade
of life, a dominant cribriform, and solid histological
pattern. A positive ER/PR and HER-2/neu status does
not seem to significantly alter the prognosis of the tumor.
However, perineural invasion may play a role in
worsening the prognosis of the tumor. It is difficult to
definitely say which treatment modality is most effective.
Perhaps, a larger study can validate our findings.
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